You searched for: dabrafenib (Maltesiska - Engelska)

doża ta’ dabrafenib
dabrafenib dose*

kombinazzjoni ma’ dabrafenib
combination with dabrafenib

dabrafenib + plaċebo (n=212)
dabrafenib + placebo (n=212)

tafinlar 50 mg kapsuli dabrafenib
tafinlar 50 mg capsules dabrafenib

is-sustanza attiva hi dabrafenib.
the active substance is dabrafenib.

effetti ta’ dabrafenib fuq sustanzi oħra
effects of dabrafenib on other substances

dabrafenib huwa inibitur ta’ kinase raf.
dabrafenib is an inhibitor of raf kinases.

modifikazzjonijiet rakkomandati fid-doża ta’ dabrafenib
recommended dabrafenib dose modifications

jekk jogħġbok ara l-smpc ta’ dabrafenib.
please see the dabrafenib smpc.

tafinlar fih is-sustanza attiva dabrafenib.
tafinlar contains the active substance dabrafenib.

effett ta’ dabrafenib fuq prodotti mediċinali oħra
effect of dabrafenib on other medicinal products

dabrafenib huwa substrat ta’ cyp2c8 u cyp3a4.
dabrafenib is a substrate of cyp2c8 and cyp3a4.

irġiel li jieħdu trametinib flimkien ma’ dabrafenib
men taking trametinib in combination with dabrafenib

jekk jogħġbok irreferi għall-smpc ta’ dabrafenib.
please refer to the dabrafenib smpc.

effetti sekondarji meta mekinist u dabrafenib jittieħdu flimkien
side effects when mekinist and dabrafenib are taken together

Ħu mekinist darba kuljum u ħu dabrafenib darbtejn kuljum.
take mekinist once daily and take dabrafenib twice daily.

għal aktar tagħrif irreferi għall-smpc ta’ dabrafenib.
refer to the dabrafenib smpc for further information.

desmethyl-dabrafenib huwa metabolizzat minn cyp3a4 għal metaboliti ossidattivi.
desmethyl-dabrafenib is metabolised by cyp3a4 to oxidative metabolites.

il-kapsuli ta’ dabrafenib għandhom jinbelgħu sħaħ mal-ilma.
the dabrafenib capsules are to be swallowed whole with water.

effetti ta’ dabrafenib fuq sistemi tat-trasport ta’ sustanzi
effects of dabrafenib on substance transport systems